Ulrich-Pur, Herbert, et al. “Phase II Trial of Pegylated Liposomal Doxorubicin (Caelyx™) Plus Gemcitabine in Chemotherapeutically Pretreated Patients With Advanced Breast Cancer”. Acta Oncologica, vol. 46, no. 2, Jan. 2007, pp. 208-13, doi:10.1080/02841860600897868.